{"schema_version":"secwatch.filing_event.v1","accession":"0001663577-26-000046","form_type":"8-K","ticker":"BPTH","cik":"0001133818","company_name":"BIO-PATH HOLDINGS, INC.","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.601833+00:00","generated_at":"2026-05-16T00:39:19.523747+00:00","sec_items":["5.01","5.03","7.1","8.1"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Bio-Path issues Series S preferred to CEO entity, giving 51% voting control; cancels reverse split, plans trial restarts","bullets":["Issued 51 Series S preferred shares (1% vote each) and 2M warrants to CEO-controlled SGA, granting 51% voting control.","$10K accrued payables used as consideration for the preferred and warrants; no new capital raised.","Filing to domesticate to Wyoming from Delaware; expected approval March 2026.","In talks with creditors to restructure; plans to restart Phase 1/2 trials for AML, solid tumors, and obesity.","Canceled previously approved 1-30 reverse split; created Strategic Advisory Board and reserved 1.5M incentive stock options."],"urls":{"canonical":"https://secwatch.observer/filing/0001663577-26-000046","json":"https://secwatch.observer/filing/0001663577-26-000046.json","markdown":"https://secwatch.observer/filing/0001663577-26-000046.md","text":"https://secwatch.observer/filing/0001663577-26-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133818/000166357726000046/0001663577-26-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133818/000166357726000046/bpth_8k022426.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:39:19.523747+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}